Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference
November 22 2016 - 10:00AM
PR Newswire (US)
BOULDER, Colo., Nov. 22, 2016 /PRNewswire/ -- Array
BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief
Executive Officer, Ron Squarer, will
speak at the Piper Jaffray Annual Healthcare conference. The
public is welcome to participate in the conference through a
webcast on the Array BioPharma
website: www.arraybiopharma.com.
|
Event:
|
Piper Jaffray Annual
Healthcare Conference
|
|
Date:
|
Tuesday, November 29,
2016
|
|
Time:
|
12:35 p.m. Eastern
Standard Time
|
About Array BioPharma
Array BioPharma Inc. is a
biopharmaceutical company focused on the discovery, development and
commercialization of targeted small molecule drugs to treat
patients afflicted with cancer. Five registration studies are
currently advancing related to three cancer drugs. These programs
include binimetinib (MEK162), encorafenib (LGX818) and selumetinib
(AstraZeneca). For more information on Array, please go to
http://www.arraybiopharma.com/.
|
CONTACT:
|
Tricia
Haugeto
|
|
Array BioPharma
Inc.
|
|
303-386-1193
|
|
thaugeto@arraybiopharma.com
|
Logo -
http://photos.prnewswire.com/prnh/20121029/LA02195LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-piper-jaffray-annual-healthcare-conference-300365720.html
SOURCE Array BioPharma
Copyright 2016 PR Newswire
Array Technologies (NASDAQ:ARRY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Array Technologies (NASDAQ:ARRY)
Historical Stock Chart
From Apr 2023 to Apr 2024
